- Visibility 262 Views
- Downloads 363 Downloads
- Permissions
- DOI 10.18231/j.ijpca.v.12.i.2.3
-
CrossMark
Blockchain technology for enhancing supply chain integrity in the pharmaceutical industry
- Author Details:
-
Sakshi Waikar *
-
Gauri Salave
-
Atul Bendale
-
Anil Jadhav
Sakshi Waikar *
Atul Bendale
Anil Jadhav
Pharmacies have to effectively oversee their data. Blockchain is a cutting-edge technology that could improve safety and transparency for a range of pharmaceutical activities. Blockchain technology is a solution to the Drug Supply Chain Security Act (DSCSA), which was passed by the US Congress in 2013 to forestall drugs that are stolen, tainted, or counterfeit. Blockchain technology is a decentralized distributed ledger that secures a peer-to-peer network of transactions leveraging cryptographic techniques. These ensure that a product is safe and appropriate for sale to consumers. Blockchain offers solutions to increase the validity, reliability, and efficiency of drug production by ensuring that laws are easily followed. It also offers an opportunity to address one of the primary problems, which is the increase of counterfeit drugs entering the market and ending up in the hands of consumers or patients. The pharmaceutical industry claims that imitation pharmaceuticals pose a severe threat to society. False prescription drugs can have a direct or indirect detrimental effect on a patient's health, occasionally resulting in serious issues or even death. This counterfeiting, which puts patient safety at risk and harms the manufacturer's reputation, is the result of the pharmaceutical industry's poor supply chain management. By offering visibility and immutability of every point in the chain, blockchain technology can be used in supply chain management to provide assurance, security, traceability, and transparency. Blockchain, a relatively new electronic data management system, holds promise for accountability and transparency. All users of a computer network can examine a blockchain, which is a ledger of transactions, as well as each user has an identical copy of the ledger.
References
- Nakamoto S. Bitcoin: A Peer-to-Peer Electronic Cash System.2008. Available from: https://nakamotoinstitute.org/library/bitcoin/. Rossetti CL, Handfield R, Dooley KJ. Forces, trends, and decisions in pharmaceutical supply chain management. Int J Phys Distr Log Manag.2011; 41(6): 601–22. Shah N. Pharmaceutical supply chains: key issues and strategies for optimisation. Computers Chem Eng.2004; 28(6-7): 929–41. Dinarvand R, Jahanbakhsh H. Evaluation and modeling of regional drug distribution in Iran. J Med Spiritual Cultivation. 2001;42: 10–
- Wisner JD, Tan KC, Leong GK. Principles of supply chain management: a balanced approach.5th ed. Thomson South Western, USA.2019 Sousa RT, Liu SS, Papageorgiou LG, Shah N. Global supply chain planning for pharmaceuticals. Chem Eng Res Des.2011;89(11): 2396–2409. Naraharisetti PK, Karimi IA. Supply chain redesign and new process introduction in multipurpose plants. Chem Eng Sci.2010;65(8):
- Juttner U, Christopher M, Baker S. Demand chain management- integrating marketing and supply chain management. Ind Mark Manag.2017; 36(3): 377–92. Deisingh AK. Pharmaceutical counterfeiting. Analyst.2005; 130(3): 271–9. McFarlane D, Sheffi Y. The impact of automatic identification on supply chain operations. Int J Log Manag.2009;16(1): 1–17. Saranga H, Phani BV. Determinants of operational efficiencies in the Indian pharmaceutical industry. Int Trans Oper Res. 2009;16(1):109–
- Koroneos G. Purdue?s RFID Pedigree Program Enters Pilot Phase.
- Pharma Tech.com. Available from: https://www.pharmtech.com/view/purdues-rfid-pedigree-program- enters-pilot-phase McCormick D. Cardinal Health Reports on RFID Pilot. ePT-the Electronic Newsletter of Pharmaceutical Technology.2006, Available from: https://www.pharmtech.com/view/cardinal-health-reports- rfid-pilot. Hua AV, Notland JS. Blockchain enabled trust & transparency in supply chain.2016. Available from: https://www.academia.edu/38200535/Blockchain_enabled_Trust_an d_Transparency_in_supply_chains. Toyoda K, Mathiopoulos PT, Sasase I and Ohtsuki T, A Novel Blockchain-Based Product Ownership Management System (POMS) for Anti-Counterfeits in the Post Supply Chain, in IEEE Access. 2017; 5:17465–77. Bocek T, Rodrigues BB, Strasser T, Stiller B. "Blockchains everywhere - a use-case of blockchains in the pharma supply-chain," 2017; 772–7. Roy SF, Jerremy M. African Counterfeit Pharmaceutical Epidemic: The Road Ahead, ACAPPP, 2009.Available from: https://a- capp.msu.edu/article/africas-counterfeit-pharmaceutical-epidemic- the-road-ahead/ "World health Organisation. Growing Threat from Counterfeit Medicines. Bull World Health Organ. 2010;88(4):2010. Penn RG. The state control of medicines: the first 3000 years. Br J Clin Pharmacol. 1979;8(4):293–305. Roxanne E, Wukoson GP, Keth LD. Anti-counterfeiting in the fashion and luxury sectors: trends and strategies, Anti-counterfeiting – A Global Guide, 2013 . Available from: https://www.worldtrademarkreview.com/global-guide/anti- counterfeiting-and-online-brand-enforcement/2013/article/anti- counterfeiting-in-the-fashion-and-luxury-sectors-trends-and- strategies Benchoufi M, Porcher R, Ravaud P. Blockchain protocols in clinical trials: Transparency and traceability of consent. F1000Res. 2018;6:66. Xia Q, Sifah EB, Asamoah KO, Gao J, Du X, Guizani M. MeDShare: Trust-Less Medical Data Sharing Among Cloud Service Providers via Blockchain. IEEE Access.2017; 5:14757–67. Azaria A, Ekblaw A, Vieira T, Lippman A. "MedRec: Using Blockchain for Medical Data Access and Permission Management," 2016 2nd International Conference on Open and Big Data (OBD), Vienna, Austria, 2016; 25–30. Mettler M, "Blockchain technology in healthcare: The revolution starts here," 2016 IEEE 18th International Conference on e-Health Networking, Applications and Services (Healthcom), Munich, Germany, 2016; 1–3. Cheng EC, Le Y, Zhou J, Lu Y. Healthcare services across China – on implementing an extensible universally unique patient identifier system. Int J Healthcare Manag.2018;11(3):210–16. Zakari N, Al-Razgan M, Alsaadi A, Alshareef H, Al Saigh H, Alashaikh L, Alharbi M. Blockchain technology in the pharmaceutical industry: A systematic review. Peer J Comput Sci. 2022:8:e840